Trading window closed from July 1 for Q1FY27 results

MARKSANS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+7.1%1-day move

₹258.00

prior close

₹256.09

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.9+0.9+1.1+2.5+7.1+3.9+3.6+2.6+0.8+2.3+3.3———

Up moveDown movePending

AI summary

Marksans Pharma has informed the exchanges that the trading window for designated persons and their immediate relatives will remain closed from Wednesday, July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ended June 30, 2026 (Q1FY27). The date of results declaration will be intimated separately. This is a routine compliance filing under SEBI's Prohibition of Insider Trading Regulations, 2015 and does not involve any insider trades being reported.

Likely market impact

Routine compliance filing with no direct impact on shareholders. Signals that Q1FY27 earnings announcement is expected within the coming weeks.